Both in Biotechnology
Black Diamond Therapeutics vs LENZ Therapeutics
Over the past year BDTX returned −49.9% and LENZ returned −91.4%; their daily moves had a correlation of 0.15.
BDTX −49.9% LENZ −91.4%Growth of $1, one year, split-adjusted
| Metric | BDTX | LENZ |
|---|---|---|
| Price | $1.87 | $3.86 |
| Market cap | $107.4M | $121.3M |
| Today | +2.19% | −2.53% |
| 1 month | −16.1% | −24.5% |
| 6 months | −7.9% | −53.4% |
| Year to date | −23.0% | −75.9% |
| 1 year | −45.0% | −90.8% |
| Revenue growth (YoY) | — | +9.7% |
| Gross margin | — | 94.9% |
| Net margin | — | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.6× |
| Net cash | $110.5M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 49.4% | 71.0% |
| Short % of float | 12.1% | 75.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).